Infectious Disease Doctors in Oldsmar, FL - Medicare Status, Address, Contact

1 Infectious Disease doctors found. Showing 1 - 1

Dr. Donald Andrew Pocock, MD
Internal Medicine - Infectious Disease
Medicare: Not Enrolled in Medicare
Practice Location: 1995 Muirfield Way, Oldsmar, FL 34677
Phone: 727-812-0236

News Archive

Step counters could play role in predicting lung cancer treatment outcomes

Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.

Maternal obesity, poor nutrition during pregnancy affect egg reserves of female child

New research involving mice, published in the April 2016 issue of The FASEB Journal, suggests that maternal obesity and poor nutrition during pregnancy affects the egg reserves of female offspring. This discovery improves scientific understanding of the long-term, generational, effects of obesity and poor nutrition. This understanding is the first step toward devising interventions to protect the fertility of females who experienced very difficult womb environments.

Altogen Biosystems releases PEG-Liposome siRNA In Vivo Transfection Kit

Altogen Biosystems announced the release of its second generation of in vivo RNAi transfection reagent in the company's popular in vivo delivery product line: PEG-Liposome siRNA In Vivo Transfection Kit. This reagent is also compatible for in vivo transfection of other negatively charged molecules – RNA, DNA, and small proteins.

Orexigen Therapeutics' committee grants an inducement stock option

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on November 18, 2009 the Compensation Committee of the Company's Board of Directors granted an inducement stock option to purchase 200,000 shares of common stock to Preston Klassen, M.D., its newly appointed Head of the Global Contrave Program.

NY-ESO-1 recombinant proteins to be used in clinical trials for treating melanoma and ovarian cancer

The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein-a cancer vaccine-that will be used in clinical trials for patients facing either ovarian cancer or melanoma. The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.

Infectious Disease Doctors in Oldsmar, FL Accepting Medicare